Results 1 to 10 of about 8,677 (75)

Update on Adjuvant Treatment in Resectable Non-Small Cell Lung Cancer and Potential Biomarkers Predicting Postoperative Relapse [PDF]

Tuberculosis and Respiratory Diseases, 2023
A significant proportion of patients with non-small cell lung cancer (NSCLC) is diagnosed in the early and resectable stage. Despite the use of platinum-based adjuvant chemotherapy, there was only a marginal increase in overall survival and a 15 ...
Jeong Uk Lim
doaj   +1 more source

Novel molecular classification of endometrial cancer - current and future clinical implications [PDF]

Vojnosanitetski Pregled, 2023
nema
Mandić Aljoša, Nađ Gabriel-Stefan, Stanulović Nevena, Maričić Slobodan, Gutić Bojana   +4 more
doaj   +1 more source

Clinical efficacy of adjuvant chemotherapy in stage IB (< 4 cm) non-small cell lung cancer patients with high-risk factors [PDF]

The Korean Journal of Internal Medicine, 2022
Background/Aims Adjuvant chemotherapy is the standard of care for resected stage II–IIIA non-small cell lung cancer (NCSLC). The efficacy of adjuvant chemotherapy in stage IB (< 4 cm) NSCLC with high-risk factors is controversial.
Juwhan Choi, Jee Youn Oh, Young Seok Lee, Kyung Hoon Min, Jae Jeong Shim, Sue In Choi, Dong Won Park, Chan Kwon Park, Eun Joo Kang, Hwan Seok Yong, Bong Kyung Shin, Hyun Koo Kim, Sung Yong Lee   +12 more
doaj   +1 more source

Differences in prognosis and underuse of adjuvant chemotherapy between elderly and non‐elderly patients in stage III colorectal cancer

Annals of Gastroenterological Surgery, 2023
Aim We aimed to clarify the use of adjuvant chemotherapy and the prognosis of elderly colorectal cancer patients compared with non‐elderly patients, and the usefulness of sarcopenia as an indicator for the introduction and completion of adjuvant ...
Takuya Shiraishi, Hiroomi Ogawa, Ikuma Shioi, Naoya Ozawa, Katsuya Osone, Takuhisa Okada, Makoto Sohda, Ken Shirabe, Hiroshi Saeki   +8 more
doaj   +1 more source

Adjuvant chemotherapy for elderly patients with gastric cancer after D2 gastrectomy. [PDF]

PLoS ONE, 2013
BACKGROUND: A phase III clinical trial has already shown the survival benefits of postoperative chemotherapy in gastric cancer. However, there are limited published data concerning the elderly.
Ying Jin, Miao-zhen Qiu, De-shen Wang, Dong-sheng Zhang, Chao Ren, Long Bai, Hui-yan Luo, Zhi-qiang Wang, Feng-hua Wang, Yu-hong Li, Rui-hua Xu   +10 more
doaj   +1 more source

Differences in the performance of adjuvant chemotherapy between hemodialysis and nonhemodialysis patients

Cancer Medicine, 2023
Background The survival of hemodialysis (HD) patients with cancer is poor, which may be caused by undertreatment due to renal dysfunction. Particularly, adjuvant chemotherapy after surgery may be considered optional because of its preventive nature. This
Taisuke Ishii, Tomone Watanabe, Takahiro Higashi   +2 more
doaj   +1 more source

Improved overall survival is associated with adjuvant chemotherapy after definitive concurrent chemoradiotherapy for N3 nasopharyngeal cancer

Scientific Reports, 2022
Concurrent chemoradiotherapy is the established treatment for locally advanced nasopharyngeal carcinoma (NPC). However, there is no evidence supporting routine adjuvant chemotherapy. We aimed to demonstrate the effect of adjuvant chemotherapy on survival
Mu-Hung Tsai, Shang-Yin Wu, Hsi-Huei Lu, Tsung Yu, Sen-Tien Tsai, Yuan-Hua Wu   +5 more
doaj   +1 more source

Adjuvant chemotherapy and survival outcomes in rectal cancer patients with good response (ypT0-2N0) after neoadjuvant chemoradiotherapy and surgery: A retrospective nationwide analysis

Frontiers in Oncology, 2022
BackgroundFor rectal cancer, it remains unclear how to incorporate tumor response to neoadjuvant chemoradiotherapy (nCRT) when deciding whether to give adjuvant chemotherapy.
Yu-Hsuan Kuo, Yu-Hsuan Kuo, Yun-Tzu Lin, Chung-Han Ho, Chung-Han Ho, Chia-Lin Chou, Chia-Lin Chou, Li-Chin Cheng, Chia-Jen Tsai, Wei-Ju Hong, Yi-Chen Chen, Ching-Chieh Yang, Ching-Chieh Yang   +12 more
doaj   +1 more source

Recent Advances in Adjuvant Therapy for Non–Small-Cell Lung Cancer [PDF]

Tuberculosis and Respiratory Diseases
After the successful development of targeted therapy and immunotherapy for the treatment of advanced-stage non-small cell lung cancer (NSCLC), these innovative treatment options are rapidly being applied in the adjuvant setting for early-stage NSCLC ...
Mi-Hyun Kim, Soo Han Kim, Min Ki Lee, Jung Seop Eom   +3 more
doaj   +1 more source

Adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: updated results of the Seoul National university hospital experience

International Brazilian Journal of Urology, 2015
Objectives: The objective of this study was to update the long-term outcome in the treatment of locally advanced upper tract urothelial carcinoma (UTUC) after radical nephroureterectomy (RNU) regarding the role of adjuvant chemotherapy.
Hyung Suk Kim, Joong Sub Lee, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, Ja Hyeon Ku   +5 more
doaj   +1 more source